Login
$FERG
$229.52 +$2.66 (1.17%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q4 FY2026
As of Jun 30, 2026
Q3 FY2026
As of Mar 31, 2026
Q1 FY2026
As of Oct 31, 2025
Q4 FY2025
As of Jul 31, 2025
Q3 FY2025
As of Apr 30, 2025
Q2 FY2025
As of Jan 31, 2025
Q1 FY2025
As of Oct 31, 2024
Q4 FY2024
As of Jul 31, 2024
Assets
Cash and cash equivalents
Accounts receivable, less allowances of $31 and $25, respectively
Inventories
Prepaid and other current assets
Assets held for sale
Total current assets
Property, plant and equipment, net
Operating lease right-of-use assets
Deferred income taxes, net
Goodwill
Other intangible assets, net
Other non-current assets
Total assets
Liabilities and stockholders’ equity
Accounts payable
Short-term debt
Current portion of operating lease liabilities
Share repurchase liability
Other current liabilities
Liabilities held for sale
Total current liabilities
Long-term debt
Long-term portion of operating lease liabilities
Other long-term liabilities
Total liabilities
Stockholders’ equity:
Ordinary shares, par value 10 pence: 500,000,000 shares authorized, 0 and 232,171,182 shares issued, respectively
Ordinary shares
Total ordinary shares, par value 10 pence: 500,000,000 shares authorized, 0 and 232,171,182 shares issued, respectively
Common stock, par value $0.0001; 500,000,000 shares authorized; 201,343,253 issued
Paid-in capital
Retained earnings
Treasury shares, 7,891,376 and 6,291,666 shares, respectively at cost
Employee Benefit Trust, 0 and 274,031 shares, respectively at cost
Accumulated other comprehensive loss
Total stockholders' equity
Total liabilities and stockholders' equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support